Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Regulatory News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Sep 2017 10:04

RNS Number : 2745R
C4X Discovery Holdings PLC
20 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

C4X DISCOVERY HOLDINGS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

CANACCORD GENUITY GROUP INC

City and country of registered office (if applicable)

VANCOUVER, CANADA

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

18 SEPTEMBER 2017

6. Date on which issuer notified (DD/MM/YYYY):

19 SEPTEMBER 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.4581%

0.00

5.4581%

46,555,087

Position of previous notification (if

applicable)

N/A

N/A

N/A

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BQQ2RV18

N/A

2,541,000

N/A

5.4581%

SUBTOTAL 8. A

2,541,000

5.4581%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Canaccord Genuity Group Inc.[1]

5.4581%

5.4581%

Canaccord Genuity Wealth Group Holdings Limited

5.4581%

5.4581%

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

5.4581%

5.4581%

Hargreave Hale Limited

5.4581%

5.4581%

[1] Each company set out in this table is ultimately owned by Canaccord Genuity Group Inc.

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

This disclosable event is as a result of the acquisition of Hargreave Hale Limited by Canaccord Genuity Group Inc., through its wholly-owned subsidiary Canaccord Genuity Wealth Group Holdings (Jersey) Limited.

 

 

 

Place of completion

London

Date of completion

19/09/17

 


 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLIFIAAIIIFID
Date   Source Headline
7th Dec 20204:05 pmRNSC4X Discovery Notice of Results
12th Nov 202012:32 pmRNSHolding(s) in Company
12th Nov 202011:36 amRNSHolding(s) in Company
12th Nov 20209:14 amRNSHoldings in Company
11th Nov 20206:12 pmRNSHoldings in Company
11th Nov 20204:44 pmRNSHolding(s) in Company
9th Nov 202011:24 amRNSResult of General Meeting and Issue of Equity
21st Oct 20203:54 pmRNSResult of Placing
21st Oct 20207:06 amRNSProposed Placing
10th Sep 202010:18 amRNSHolding(s) in Company
2nd Sep 202010:19 amRNSHolding(s) in Company
25th Aug 20207:00 amRNSBusiness Update
18th Aug 202011:05 amRNSSecond Price Monitoring Extn
18th Aug 202011:00 amRNSPrice Monitoring Extension
29th Jul 20202:54 pmRNSCancellation and Regrant of Existing Share Options
21st Jul 20202:02 pmRNSHoldings in Company
5th Jun 20207:00 amRNSClive Dix appointed to the UK Vaccine Taskforce
13th May 20203:28 pmRNSHoldings in Company
12th May 20206:23 pmRNSHolding(s) in Company
12th May 20202:02 pmRNSHolding(s) in Company
7th May 202012:36 pmRNSResult of Placing
7th May 20207:00 amRNSProposed Placing
29th Apr 20209:00 amRNSPrice Monitoring Extension
29th Apr 20207:00 amRNSInterim results
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSNotice of Results
30th Mar 20202:06 pmRNSSecond Price Monitoring Extn
30th Mar 20202:01 pmRNSPrice Monitoring Extension
31st Jan 202012:24 pmRNSResult of AGM
17th Jan 20209:00 amRNSNotice of AGM and Posting of 2019 Annual Report
7th Jan 20207:00 amRNSFull Year Results
12th Dec 201911:04 amRNSNotice of Full Year Results
9th Dec 20191:20 pmRNSAltasciences appointed by Indivior
5th Dec 20192:24 pmRNSGrant of Options
19th Nov 20193:38 pmRNSDirector Dealings
19th Nov 20197:00 amRNSHoldings in Company
18th Nov 20193:02 pmRNSHoldings in Company
18th Nov 20193:00 pmRNSHoldings in Company
18th Nov 20192:58 pmRNSHoldings in Company
13th Nov 201911:21 amRNSResult of General Meeting
24th Oct 20194:40 pmRNSSecond Price Monitoring Extn
24th Oct 20194:35 pmRNSPrice Monitoring Extension
24th Oct 20194:02 pmRNSResults of Placing
24th Oct 20197:00 amRNSProposed Placing, Subscription and Open Offer
1st Oct 20197:00 amRNSBusiness update
27th Sep 20194:41 pmRNSSecond Price Monitoring Extn
27th Sep 20194:35 pmRNSPrice Monitoring Extension
27th Sep 20199:40 amRNSIndivior awarded NIH HEAL grant for C4X3256
2nd Sep 20197:00 amRNSC4XD forms Drug Discovery Advisory Network

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.